Are drugs designed to work best for all patients?
Are randomised controlled trials achieving the results we need for patients? In the latest instalment of ERS Vision, Professor Elisabeth Bel leads a discussion on the relevance of real-life evidence and whether it can enhance existing guidelines.
The documentary considers how we can ask the right questions to provide the right solutions for each individual patient. Leading experts consider the value of this type of research, along with the issues surrounding quality standards, costs and how it can be effectively designed and applied.
European Respiratory Society: Should we be testing new drugs in the ‘real’ world where some patients smoke, are obese and have other comorbidities?
Share this post
Latest News posts
Poetry at the GAFFI Launch
January 23, 2019
Decomposition: An Anthology of Fungi-Inspired Poems
January 23, 2019
11 irregular stanzas on trimming toenails by Kat Couch
January 23, 2019
Soup’s On! by Del Maximo
January 23, 2019
Some Drs are odd by Mr Bigglesworth
January 23, 2019
GROWING THE ART OF YOUR SCIENCE By Andrew Newman
January 23, 2019
THE FOREST’S FLOORS By Luke Heaton
January 23, 2019
MUSCARIA IN MIND – by Ted Tuddenham
January 23, 2019
PLAYFUL BOYS – By Elizabeth Sheedy
January 23, 2019
The fungal thread of death by John Lucas
January 23, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video